Picture of Biofrontera logo

BFRI — Biofrontera News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biofrontera Inc expected to post a loss of 42 cents a share - Earnings Preview

Biofrontera Inc BFRI.OQ BFRI.O is expected to  show a rise in quarterly revenue when it reports  results on August 13 for the period ending June 30 2025

The Woburn Massachusetts-based  company is expected to report a 5.9% increase in revenue to $8.3 million from $7.84 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Biofrontera Inc is for a loss of 42 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Biofrontera Inc is $6.38, about 85.2% above its last closing price of $0.95

This summary was machine generated August 11 at 20:47 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Biofrontera

See all news